Shreekrishna Biotech has informed that the meeting of the Board of Directors of the Company will be held on February 13, 2017, to consider the unaudited financial results of the company for quarter and year ending December 31, 2016. As per ‘Code of Internal Procedure and Conduct for Prevention of Insider Trading’ in Shares of the Company (‘Code’), the trading window will remain closed from January 31, 2017 to February 14, 2017 in connection with the announcement of the unaudited financial results of the company for quarter and year ending December 31, 2016 for Directors and other employees of the Company covered under the Code. The trading window will reopen on February 14, 2017.The above information is a part of company’s filings submitted to BSE.

Shreekrishna Biotech has informed that the 31st Annual General Meeting (AGM) of the Company was held on September 28, 2015.The above information is a part of company’s filings submitted to BSE.

Shreekrishna Biotech has informed about Disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015.The above information is a part of company’s filings submitted to BSE.

Shreekrishna Biotech has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.The above information is a part of company’s filings submitted to BSE.

Shreekrishna Biotech has informed that the Board of Directors of the Company at its meeting held on December 20, 2014, to Appoint Sunil Nerli as additional Director on December 11, 2014 and to accept resignation of Vipul Joshi on December 11, 2014 from the Board of Director of the Company.The above information is a part of company’s filings submitted to BSE.

Shreekrishna Biotech has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992The above information is a part of company’s filings submitted to BSE

Shreekrishna Biotech has informed that the Board of Directors of the Company at its meeting held on August 25, 2014, Pankaj Desai, Company Secretary (in whole-time Practice) has been appointed as the scrutinizer to conduct e-voting in free, fair and transparent manner.The above information is a part of company’s filings submitted to BSE

Shreekrishna Biotech has informed that at the Meeting of the Board of Directors of the Company held on December 16, 2013 and the approval of the shareholders on meeting held on September 05, 2013 it has been decided to allot 10,000,000 Convertible Warrants on preferential basis to other than promoter.The above information is a part of company’s filings submitted to BSE.

Shreekrishna Biotech has informed about the Financial Results for the period ended September 30, 2013.The above information is a part of company’s filings submitted to BSE.

Shreekrishna Biotech has informed about the Financial Results for the period ended March 31, 2013.The above information is a part of company’s filings submitted to BSE.

Shreekrishna Biotech has informed about the financial results for the period ended December 31, 2012.The above information is a part of company’s filings submitted to BSE.

Shreekrishna Biotech has informed about the financial results for the period ended September 30, 2012.The above information is a part of company's filings submitted to BSE.